Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0C3YN
|
||||
Former ID |
DIB016404
|
||||
Drug Name |
Heparin low molecular weight
|
||||
Synonyms |
Heparin low molecular weight, Watson Laboratories; Heparin transmucosal, TheraTech
|
||||
Indication | Thrombosis [ICD9: 437.6, 453, 671.5, 671.9; ICD10:I80-I82] | Phase 3 | [528250] | ||
Company |
Watson Laboratories Inc
|
||||
Target and Pathway | |||||
Target(s) | Antithrombin-III | Target Info | Modulator | [534104] | |
KEGG Pathway | Complement and coagulation cascades | ||||
PANTHER Pathway | Blood coagulation | ||||
Pathway Interaction Database | Glypican 1 network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.